JP2022517442A5 - - Google Patents

Info

Publication number
JP2022517442A5
JP2022517442A5 JP2021563433A JP2021563433A JP2022517442A5 JP 2022517442 A5 JP2022517442 A5 JP 2022517442A5 JP 2021563433 A JP2021563433 A JP 2021563433A JP 2021563433 A JP2021563433 A JP 2021563433A JP 2022517442 A5 JP2022517442 A5 JP 2022517442A5
Authority
JP
Japan
Application number
JP2021563433A
Other languages
Japanese (ja)
Other versions
JPWO2020148526A5 (https=
JP2022517442A (ja
Filing date
Publication date
Priority claimed from GBGB1900526.3A external-priority patent/GB201900526D0/en
Application filed filed Critical
Publication of JP2022517442A publication Critical patent/JP2022517442A/ja
Publication of JPWO2020148526A5 publication Critical patent/JPWO2020148526A5/ja
Publication of JP2022517442A5 publication Critical patent/JP2022517442A5/ja
Pending legal-status Critical Current

Links

JP2021563433A 2019-01-15 2020-01-15 Caixに特異的な二環式ペプチドリガンド Pending JP2022517442A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1900526.3 2019-01-15
GBGB1900526.3A GB201900526D0 (en) 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for caix
PCT/GB2020/050070 WO2020148526A1 (en) 2019-01-15 2020-01-15 Bicyclic peptide ligands specific for caix

Publications (3)

Publication Number Publication Date
JP2022517442A JP2022517442A (ja) 2022-03-08
JPWO2020148526A5 JPWO2020148526A5 (https=) 2023-01-25
JP2022517442A5 true JP2022517442A5 (https=) 2023-01-25

Family

ID=65528170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563433A Pending JP2022517442A (ja) 2019-01-15 2020-01-15 Caixに特異的な二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220133732A1 (https=)
EP (1) EP3911743A1 (https=)
JP (1) JP2022517442A (https=)
CN (1) CN113383074A (https=)
GB (1) GB201900526D0 (https=)
WO (1) WO2020148526A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
JP7301757B2 (ja) 2017-06-26 2023-07-03 バイスクルアールディー・リミテッド 検出可能部分を持つ二環式ペプチドリガンドおよびその使用
CN111183147B (zh) 2017-08-04 2024-07-05 拜斯科技术开发有限公司 Cd137特异性的双环肽配体
JP2021514953A (ja) 2018-02-23 2021-06-17 バイスクルテクス・リミテッド 多量体二環式ペプチドリガンド
IL279489B2 (en) 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
US12551567B2 (en) 2018-12-21 2026-02-17 Bicyclerd Limited Bicyclic peptide ligands specific for PD-L1
JP2022514618A (ja) 2018-12-21 2022-02-14 バイスクルテクス・リミテッド Pd-l1に特異的な二環式ペプチドリガンド
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
IL300248A (en) 2020-08-03 2023-03-01 Bicycletx Ltd peptide-based linkers
US20250339569A1 (en) 2021-12-17 2025-11-06 3B Pharmaceuticals Gmbh Carbonic anhydrase ix ligands
CN118852348A (zh) * 2022-02-11 2024-10-29 C-比奥麦克斯有限公司 靶向碳酸酐酶ix的肽配体、包含其的肽结构体及它们的用途
CN117599013A (zh) * 2022-08-22 2024-02-27 赣州和美药业股份有限公司 纳米组合物及其制备方法和用途
CN120230182B (zh) * 2025-05-29 2025-08-22 北京肿瘤医院(北京大学肿瘤医院) 经修饰的caix靶向环肽及其核素标记物与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
DK1844337T3 (da) 2005-01-24 2013-09-30 Pepscan Systems Bv Bindingsforbindelser, immunogene forbindelser og peptidmimetika
AU2009211253B2 (en) 2008-02-05 2014-11-06 Bicyclerd Limited Methods and compositions
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
GB201607827D0 (en) * 2016-05-04 2016-06-15 Bicycle Therapeutics Ltd Bicyclic peptide-toxin conjugates specific for MT1-MMP
WO2018197893A1 (en) * 2017-04-27 2018-11-01 Bicycletx Limited Bicyclic peptide ligands and uses thereof
JP7301757B2 (ja) * 2017-06-26 2023-07-03 バイスクルアールディー・リミテッド 検出可能部分を持つ二環式ペプチドリガンドおよびその使用

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)